Novel fluorescence lifetime imaging may complement BluePeak for prediction of progression in Stargardt disease
Since its introduction, BluePeak blue laser autofluorescence has become a widely established scanning laser fundus imaging modality to provide a map of the retina which can reveal metabolic malfunction of diagnostic significance in many conditions.
